Pharming Group N.V.
PHARM.AS · AMS
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | €973,439 | €718,012 | €562,200 | €708,793 |
| - Cash | €132,370 | €92,091 | €60,093 | €54,944 |
| + Debt | €130,922 | €128,326 | €119,143 | €112,313 |
| Enterprise Value | €971,991 | €754,247 | €621,250 | €766,162 |
| Revenue | €97,287 | €93,221 | €79,094 | €92,672 |
| % Growth | 4.4% | 17.9% | -14.7% | – |
| Gross Profit | €90,216 | €84,249 | €70,771 | €80,459 |
| % Margin | 92.7% | 90.4% | 89.5% | 86.8% |
| EBITDA | €23,430 | €9,785 | -€4,108 | €15,626 |
| % Margin | 24.1% | 10.5% | -5.2% | 16.9% |
| Net Income | €7,548 | €4,694 | -€14,719 | €2,859 |
| % Margin | 7.8% | 5% | -18.6% | 3.1% |
| EPS Diluted | 0.011 | 0.007 | -0.022 | 0.005 |
| % Growth | 61.4% | 131.8% | -558.3% | – |
| Operating Cash Flow | €32,026 | €11,743 | €232 | €9,331 |
| Capital Expenditures | -€70 | -€128 | -€288 | -€136 |
| Free Cash Flow | €31,956 | €11,615 | -€56 | €9,195 |